You May Also Like
Sponsored
Sold by Mighty Ape
The present study is an “open randomized controlled trial” using single low dose (25 μg) misoprostol vaginally as an intervention in study group at 40 weeks of gestation in uncomplicated singleton pregnancies to prevent prolonged pregnancy with control group receiving no intervention. The study and control groups showed significant difference in number of women entering labor within 1 week of enrolment. Induction was needed in only 7.7% (5/65) of women in the study group, whereas in the control group, induction was required in 27.7% (18/65) of women. Mean duration from enrolment in study till delivery was 1.33±2.03 days in study group and 4.98±2.74 days in control group. Cesarean section was required in 13.9% (9/65) and 15.4% (10/65) in study and control groups respectively. Women in study group did not have any side effects. Mean birth weight, meconium stained liquor rate, NICU admission rate and neonatal morbidity were found to be comparable in both the groups. No neonatal or perinatal mortality was observed in either group.
We are committed to protecting your rights under the Consumer Guarantees Act and working with our suppliers to assist with warranty claims. Products sold by Mighty Ape will be covered by a Manufacturer's Warranty for at least a one-year period from the date of purchase.
Your warranty will cover any manufacturing defects which, if existing, will present themselves within this warranty period.
Your warranty will not cover normal wear and tear, faults caused by misuse, and accidents which cause damage or theft caused after delivery. Using the product in a way it is not designed for will void your warranty.
Please refer to our Help Centre for more information.
